Ineffectiveness of dialysis in transthyretin (TTR) clearance in Familial Amyloid Polyneuropathy type I, in spite of lower stability of the TTR Met30 variant

Clinical Nephrology

Volumn 51, Issue 1, 1999, Pages 45-49

  Beirao I ^a,b   Lobato, L ^a,b   Riedstra, S ^b,c   Costa, P M P ^b   Pimentel, S ^a   Guimaraes S ^a  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH   (Portugal)

^c CBQF CENTRO DE BIOTECNOLOGIA E QUÍMICA FINA LABORATÓRIO ASSOCIADO   (Portugal)

Author keywords

End stage renal disease; Familial Amyloid Polyneuropathy; Hemodiafiltration; Hemodialysis; Transthyretin

Indexed keywords

CELLULOSE; POLYSULFONE; PREALBUMIN;

ADULT; AGED; AMYLOID NEUROPATHY; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DIALYSIS MEMBRANE; FEMALE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY DISEASE; MALE;

AMYLOID NEUROPATHIES; FEMALE; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PREALBUMIN; RENAL DIALYSIS; TIME FACTORS;

EID: 0032924669     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Andrade C 1952 A peculiar form of peripheral neuropathy. Familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75: 408-427
2. Beirão I, Lobato L, Silva M, Coelho T, Xavier E. Guimarães S 1996 Clinical course and outcome in patients with familial amyloid polyneuropathy (FAP) TTR Met30 on regular dialysis. Neurumuscular Disorders 6 (Suppl 1): S53
3. Blake CCF, Geisow MJ, Oatley SJ, Rérat B, Rérat C 1978 Structure of prealbumin: secondary, tertiary and quaternary interaction determined by Fourier refinement at 1.8 A. J Mol Biol 121: 339-356
4. Colón W, Kelley J 1992 Partial denaturation of transthyretin is sufficient for amyloid fibril formation. Biochemistry 31: 8654-8660
5. Gallo G, Wisniewski T, Choi-Miura N-H, Frangione B 1994 Potential role of apolipoprotein-E in fibrillogenesis. Am J Pathol 145: 526-530
6. Henderson LW 1996 Biophysis of ultrafiltration and hemofiltration. In: Jacobs C, Kjelbbtrand CM, Koch KM, Winchester JF (eds): Replacement of renal function by dialysis. Kluwer Academic Publishers. Dordrecht. 114-145
7. Kanda Y, Goodman DS, Canfield RE, Morgan FJ 1974 The amino acid sequence of human plasma prealbumin. J Biol Chem 249: 6796-6805
8. Laurell CB 1966 Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15: 45-52
9. Lobato L, Beirão I, Monteiro P, Saraiva MJM, Coelho T, Sousa A 1996 Epidemiology and genetic analysis in patients with familial amyloid polyneuropathy (FAP) type I and end-stage renal disease: Can we predict kidney involvement? Neuromuscular Disorders 6 (Suppl 1): S51
10. Makover A, Moriwaki H, Ramakrishnan R, Saraiva MJM, Blaner WS, Goodman DS 1988 Plasma Transthyretin. Tissues sites of degradation and turnover in the rat. J Biol Chem 263: 8598-8603
11. Mason JB, Rosenberg IH 1994 Protein energy malnutrition. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds): Harrison's, Principles of internal medicine. McGraw-Hill, New York, 440-446
12. McCutchen SL, Colón W, Kelley JW 1993 Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry 32: 12119-12127
13. McCutchen SL, Lai Z, Miroy GJ, Kelly JW, Colón W 1995 Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease. Biochemistry 34: 13527-13536
14. Pepys MB 1988 Amyloidosis: some recent developments. Quart J Med 67: 283-298
15. Pettersson T, Carlström A, Jörnvall H 1987 Different types of microheterogeneity of human thyroxine-binding prealbumin. Biochemistry 26: 4572-4583
16. Saraiva MJM, Costa PP 1990 Molecular biology of amyloidogenesis in the transthyretin related amyloidosis. In: Natvig JB, Forre O, Husby G, Husebekk A, Skogen B, Sletten K, Westermark P (eds): Amyloid and Amyloidosis. Kluwer, Dordrecht, 569-574
17. Skinner M, Connors LH, Rubinow A, Libbey C, Sipe JD. Cohen AS 1985 Lowered prealbumin levels in patients with familial amyloid polyneuropathy (FAP) and their non-affected but at risk relatives. Am J Med Sci 289: 17-21
18. Sousa A, Cuelho T, Barros J, Sequeiros J 1995 Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (North of Portugal). Am J Med Gen 60: 512-521
19. Sparkes RS, Sasaki H, Mohandas T, Yoshioka K, Klisak I, Sasaki Y, Heinzmann C, Simon MI 1987 Assignment of the human prealbumin (PALB) gene to human chromosome region 18q11.2-q12.1. Hum Genet 75: 151-154
20. Vahlquist A, Peterson PA, Wibell L 1973 Metabolism of the vitamin A transporting protein complex - I. Turnover studies in normal persons and in patients with chronic renal failure. Eur J Clin Invest 3: 352-362
21. Westermark P, Sletten K, Johansson B, Cornwell III GG 1990 Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 87: 2843-2845